Cargando…

Evolution of SARS-CoV-2 virus and assessment of the effectiveness of COVID-19 vaccine

A safe and effective vaccine is urgently needed to bring the current SARS-CoV-2 pandemic under control. The spike protein (SP) of SARS-CoV-2 represents the principal target for most vaccines currently under development. Despite the presence of a CoV proof-reading function in viral replication, SP pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veljkovic, Veljko, Perovic, Vladimir, Chambers, Isabelle, Paessler, Slobodan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490287/ https://www.ncbi.nlm.nih.gov/pubmed/36247800 http://dx.doi.org/10.12688/f1000research.28215.1

Ejemplares similares

Novel Entropy-Based Phylogenetic Algorithm: A New Approach for Classifying SARS-CoV-2 Variants
por: Perovic, Vladimir, et al.
Publicado: (2023)

Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach
por: Sencanski, Milan, et al.
Publicado: (2022)

Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target
por: Veljkovic, Veljko, et al.
Publicado: (2021)

Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection
por: Veljkovic, Veljko, et al.
Publicado: (2016)

Prediction of influenza vaccine effectiveness for the influenza season 2017/18 in the US
por: Paessler, Slobodan, et al.
Publicado: (2017)

Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China
por: Veljkovic, Veljko, et al.
Publicado: (2016)

Using electronic biology based platform to predict flu vaccine efficacy for 2018/2019
por: Paessler, Slobodan, et al.
Publicado: (2018)

Simple Chemoinformatics Criterion Using Electron Donor-Acceptor Molecular Characteristics for Selection of Antibiotics Against Multi-Drug-Resistant Bacteria
por: Veljkovic, Veljko, et al.
Publicado: (2016)

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease
por: Veljkovic, Veljko, et al.
Publicado: (2015)

A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy diet
por: Veljkovic, Veljko, et al.
Publicado: (2017)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
por: Sencanski, Milan, et al.
Publicado: (2020)

In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D
por: Protić, Sara, et al.
Publicado: (2023)

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors
por: Radosevic, Draginja, et al.
Publicado: (2019)

Luminore CopperTouch Surface Coating Effectively Inactivates SARS-CoV-2, Ebola Virus, and Marburg Virus In Vitro
por: Mantlo, Emily K., et al.
Publicado: (2021)

Luminore CopperTouch™ surface coating effectively inactivates SARS-CoV-2, Ebola, and Marburg viruses in vitro
por: Mantlo, Emily K., et al.
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

B cell persistence and evolution to SARS-CoV-2
por: Alrubayyi, Aljawharah
Publicado: (2020)

Antiviral activities of type I interferons to SARS-CoV-2 infection
por: Mantlo, Emily, et al.
Publicado: (2020)

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection
por: Mantlo, Emily, et al.
Publicado: (2020)

Anti-SARS-CoV-2 vaccine in liver transplantation
por: Kotsiliti, Eleni
Publicado: (2022)

SARS-CoV-2 vaccine safe for young patients
por: Onuora, Sarah
Publicado: (2022)

SARS-CoV-2 vaccine — think globally, act locally
por: Gea-Mallorquí, Ester, et al.
Publicado: (2020)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium
por: Reyna, Rachel A., et al.
Publicado: (2022)

In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation
por: Mantlo, Emily, et al.
Publicado: (2020)

Efficacy of a novel iodine complex solution, CupriDyne, in inactivating SARS-CoV-2
por: Mantlo, Emily, et al.
Publicado: (2020)

Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines
por: Belizário, J.E.
Publicado: (2021)

Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control
por: Veljkovic, Veljko, et al.
Publicado: (2009)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

SARS-CoV-2 in penile tissue
por: Thomas, Tim
Publicado: (2022)

Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece
por: Malli, Foteini, et al.
Publicado: (2023)

Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue Explants
por: Bui, Christine H T, et al.
Publicado: (2021)

Comparing neurological complications after COVID-19 vaccination and SARS-CoV-2 infection
por: Flemming, Alexandra
Publicado: (2021)

Social distancing plus rapid vaccination prevents emergence of SARS-CoV-2 variants
por: Bordon, Yvonne
Publicado: (2022)

The Uro-oncology Patient and Vaccination Against SARS-CoV-2
por: Rodriguez Socarrás, Moises, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tqnj3oqkvdhf24ccpr2n78j6p0